Solution: Data Science by Equity Risk Sciences
Due Diligence: Equity Risk Sciences can provide investors over 1,000 reports and articles to demonstrate and explain the efficacy and reliability of our technology
The most comprehensive demonstration of our technology
is our Benchmark Study.
ERS will effectively compete and win business away from the largest and most successful Wall Street research providers. We know who our competition is. We studied their products and have absolute confidence in the superiority and much higher value of our technology as compared to theirs. We intend to serve retail investors, registered investment advisors, brokerage firms, insurance companies, mutual funds, family offices, mid-sized and large financial institutions, non-profit organizations, pensions and endowments.
- March 2000: ERS’s Proprietary Stock Selection vs NASDAQ
- The Performance of ERS’s Ratings in the Past 2 Years
- ERS Analyzed 1,000,000 Stock Ratings and Picked the Best
- Consistent, Reliable Efficacy in the Worst of Times
- ERS’s Performance in Flat Markets
- The S&P 500 is Down 15% Over 5 Years
- 7-Year Study When the S&P 500 Was Down 7%
- Buying at the Top of the Market